Ensign Peak Advisors
CL icon

Ensign Peak Advisors’s Colgate-Palmolive CL Stock Holding History

Ensign Peak Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.5M Buy
921,405
+59,693
+7% +$5.22M 0.14% 137
2026
Q1 		$73.4M Buy
861,712
+296,697
+53% +$26.4M 0.14% 148
2025
Q4 		$44.6M Sell
565,015
-56,071
-9% -$4.4M 0.08% 196
2025
Q3 		$49.6M Sell
621,086
-18,849
-3% -$1.61M 0.08% 198
2025
Q2 		$58.2M Sell
639,935
-15,578
-2% -$1.42M 0.1% 182
2025
Q1 		$61.4M Sell
655,513
-31,345
-5% -$2.81M 0.12% 168
2024
Q4 		$62.4M Sell
686,858
-16,948
-2% -$1.62M 0.11% 165
2024
Q3 		$73.1M Buy
703,806
+30,234
+4% +$3.08M 0.13% 137
2024
Q2 		$65.4M Sell
673,572
-7,560
-1% -$697K 0.12% 149
2024
Q1 		$61.3M Buy
681,132
+272,635
+67% +$23.1M 0.11% 173
2023
Q4 		$32.6M Sell
408,497
-220,403
-35% -$16.6M 0.06% 244
2023
Q3 		$44.7M Sell
628,900
-55,822
-8% -$4.17M 0.1% 179
2023
Q2 		$52.8M Buy
684,722
+40,160
+6% +$3.11M 0.11% 168
2023
Q1 		$48.4M Buy
644,562
+164,520
+34% +$12.2M 0.1% 176
2022
Q4 		$37.8M Sell
480,042
-52,746
-10% -$3.95M 0.09% 208
2022
Q3 		$37.4M Buy
532,788
+68,110
+15% +$5.34M 0.09% 193
2022
Q2 		$37.2M Sell
464,678
-163,165
-26% -$12.8M 0.09% 197
2022
Q1 		$47.6M Buy
627,843
+135,405
+27% +$10.7M 0.1% 182
2021
Q4 		$42M Buy
492,438
+125,106
+34% +$9.77M 0.08% 212
2021
Q3 		$27.8M Buy
367,332
+138,186
+60% +$11M 0.06% 267
2021
Q2 		$18.6M Sell
229,146
-136,546
-37% -$11.2M 0.04% 328
2021
Q1 		$28.8M Sell
365,692
-100,627
-22% -$7.89M 0.06% 251
2020
Q4 		$39.9M Sell
466,319
-41,871
-8% -$3.46M 0.09% 197
2020
Q3 		$39.2M Sell
508,190
-59,451
-10% -$4.53M 0.1% 173
2020
Q2 		$41.6M Buy
567,641
+157,862
+39% +$11.2M 0.11% 154
2020
Q1 		$27.2M Sell
409,779
-89,175
-18% -$6.29M 0.09% 170
2019
Q4 		$34.3M Buy
+498,954
New +$34M 0.09% 191

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Ensign Peak Advisors's CL Position: Q2 2026 in Review

Ensign Peak Advisors increased its Colgate-Palmolive (CL) stake by 6.9% in Q2 2026, buying an estimated $5.22M and bringing the position to 921,405 shares worth $84.5M. The position accounts for 0.14% of the portfolio, ranked #137.

Ensign Peak Advisors first reported a position in CL in Q4 2019 and has held it in 27 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Ensign Peak Advisors held 921,405 shares of Colgate-Palmolive worth $84.5M as of Q2 2026.
  • Ensign Peak Advisors bought 59,693 Colgate-Palmolive shares in Q2 2026, an estimated $5.22M.
  • Colgate-Palmolive made up 0.14% of Ensign Peak Advisors's portfolio in Q2 2026, its #137 holding.
  • Ensign Peak Advisors first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 27 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.